The Falsified Medicines Directive, or FMD, is a set of legislation passed by the European Union Parliament, it is designed to protect patients by addressing the issue of falsified medicines entering the legitimate medicines supply chain within Europe.
All European pharmaceutical manufacturers are required to adhere to FMD by 9th February 2019, you can see more about what Accord are doing to ensure we are FMD compliant by downloading our FAQ document below.
Sandra Lee, Managing Director of Operations, explains why FMD is important and how the industry is preparing.